The prognostic molecular markers in hepatocellular carcinoma
Open Access
- 1 January 2002
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 8 (3) , 385-392
- https://doi.org/10.3748/wjg.v8.i3.385
Abstract
The prognostic molecular markers in hepatocellular carcinomaKeywords
This publication has 117 references indexed in Scilit:
- Analysis of loss of heterozygosity for chromosome 10 in patients with malignant astrocytic tumors: correlation with patient age and survivalJournal of Neurosurgery, 2001
- Reck Gene Expression in Hepatocellular Carcinoma: Correlation With Invasion–Related Clinicopathological Factors and Its Clinical SignificanceHepatology, 2001
- Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interestOncogene, 2000
- Expression and Possible Role of ets-1in Hepatocellular CarcinomaAmerican Journal of Clinical Pathology, 2000
- p53 NUCLEAR ACCUMULATION IS NOT ASSOCIATED WITH DECREASED DISEASE-FREE SURVIVAL IN PATIENTS WITH NODE POSITIVE TRANSITIONAL CELL CARCINOMA OF THE BLADDERJournal of Urology, 2000
- OUTCOME PREDICTION WITH p53 IMMUNOSTAINING AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCERJournal of Urology, 2000
- The Ki-67 protein: From the known and the unknownJournal of Cellular Physiology, 2000
- The prognostic value of p53 and c-erb b-2 immunostaining is overrated for patients with lymph node negative breast carcinomaCancer, 2000
- TP53Mutation is an Independent Prognostic Marker for Poor Outcome in Both Node-negative and Node-positive Breast CancerActa Oncologica, 2000
- Expression of proliferation associated antigens and detection of numerical chromosome aberrations in primary human liver tumours: relevance to tumour characteristics and prognosisJournal of Clinical Pathology, 1998